Kimberly Schafer

6.2k citations

38 papers · 4.7k indexed · 2 hit papers · h-index 21

Impact in

Biological Psychiatry top 1%
- Tryptophan and brain disorders
Psychiatry and Mental health top 0.5%
- Dementia and Cognitive Impairment Research

Papers in

Psychiatry and Mental health 14
- Dementia and Cognitive Impairment Research 13
- Schizophrenia research and treatment 3
Biological Psychiatry 2
- Tryptophan and brain disorders 2

Co-authors: Mary Sano Ronald G. Thomas Michael Grundman Leon J. Thal Christopher Ernesto Eric Pfeiffer Lon S. Schneider John H. Growdon
Journals: Alzheimer Disease & Associated Disorders (6 papers)Neurology (3 papers)Alzheimer s & Dementia (2 papers)Alcoholism Clinical and Experimental Research (2 papers)Controlled Clinical Trials (2 papers)
Partner nations: United States Germany Estonia

In The Last Decade

Kimberly Schafer

37 papers receiving 4.4k citations

Hit Papers

align trajectories log scale

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. 2003 · 744 citations

Peers

Countries citing papers authored by Kimberly Schafer

Since Specialization

Citations

This map shows the geographic impact of Kimberly Schafer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Schafer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Schafer more than expected).

Fields of papers citing papers by Kimberly Schafer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Schafer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Schafer. The network helps show where Kimberly Schafer may publish in the future.

Co-authors

The 25 scholars most cited alongside Kimberly Schafer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kimberly Schafer Line = papers co-authored together Kimberly Schafer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Recruitment of a multi‐site randomized controlled trial of aerobic exercise for older adults with amnestic mild cognitive impairment: The EXERT trial Alzheimer s & Dementia ·Aladdin H. Shadyab, Andrea Z. LaCroix, Howard Feldman, Christopher H. van Dyck, Ozioma C. Okonkwo, Steven Tam, J. Kaci Fairchild, Kathleen A. Welsh‐Bohmer, Genevieve Matthews, Daniel Bennett, (unknown), (unknown), Kimberly Schafer, Rosemary Morrison, Sean A. Kipperman, Jennifer Mason, Donna Tan, Ronald G. Thomas, Carl W. Cotman, Laura D. Baker, (unknown)	2021	11
2	Impact of potential modifications to Alzheimer’s disease clinical trials in response to disruption by COVID-19: a simulation study Alzheimer s Research & Therapy ·Lon S. Schneider, Yuqi Qiu, Ronald G. Thomas, Carol Evans, Diane M. Jacobs, Shelia Jin, Jeffrey Kaye, Andrea Z. LaCroix, Karen Messer, David P. Salmon, Mary Sano, Kimberly Schafer, Howard Feldman	2021	4
3	Errors in ADAS-Cog Administration and Scoring May Undermine Clinical Trials Results Current Alzheimer Research ·Kimberly Schafer, Susan De Santi, L. S. Schneider	2011	10
4	Prophylactic treatment with recombinant Eimeria protein, alone or in combination with an agonist cocktail, protects mice from Banzi virus infection Antiviral Research ·Justin G. Julander, John W. Judge, Ann‐Karin Olsen, Barbara F. Rosenberg, Kimberly Schafer, R. W. Sidwell	2006	5
5	Die ultraschalltopometrische Quantifizierung der Wirbelsäulenform und der Halteleistungsfähigkeit für die Evaluation verschiedener Muskelkräftigungsprogramme in der Therapie von Rückenschmerzen Zeitschrift für Orthopädie und ihre Grenzgebiete ·S. Dalichau, B M Stein, Kimberly Schafer, J. Buhlmann, P. Menken	2005	2
6	A multicenter, randomized, placebo controlled, multiple-dose, safety and pharmacokinetic study of AIT-082 (Neotrofin™) in mild Alzheimer's disease patients Life Sciences ·Michael Grundman, Edmund V. Capparelli, H.T Kim, John C. Morris, Martin Farlow, Eugene H. Rubin, Judith L. Heidebrink, Alexander Hake, Gilbert Ho, Arlan N. Schultz, Kimberly Schafer, Wes S. Houston, Ronald G. Thomas, L. J. Thal	2003	27
7	Interobserver Disagreements on Clinical Dementia Rating Assessment: Interpretation and Implications for Training Alzheimer Disease & Associated Disorders ·Rochelle E. Tractenberg, Kimberly Schafer, John C. Morris	2001	23
8	Treatment of agitation in AD Neurology ·Linda Teri, Rebecca G. Logsdon, Elaine R. Peskind, Murray A. Raskind, Myron Weiner, Rochelle E. Tractenberg, Norman L. Foster, Lon S. Schneider, Mary Sano, Peter J. Whitehouse, Pierre N. Tariot, Alan M. Mellow, Alexander P. Auchus, Michael Grundman, Ronald G. Thomas, Kimberly Schafer, L. J. Thal	2000	229
9	A Multicenter Evaluation of New Treatment Efficacy Instruments for Alzheimerʼs Disease Clinical Trials Alzheimer Disease & Associated Disorders ·Steven H. Ferris, Joan Mackell, Richard C. Mohs, Lon S. Schneider, Douglas Galasko, Peter J. Whitehouse, Frederick A. Schmitt, Mary Sano, Ronald G. Thomas, Christopher Ernesto, Michael Grundman, Kimberly Schafer, Leon J. Thal	1997	37
10	The Severe Impairment Battery Alzheimer Disease & Associated Disorders ·Frederick A. Schmitt, Wesson Ashford, Christopher Ernesto, Judith Saxton, Lon S. Schneider, Christopher M. Clark, Steven H. Ferris, Joan Mackell, Kimberly Schafer, Leon J. Thal	1997	126
11	Assessing Patterns of Agitation in Alzheimerʼs Disease Patients with the Cohen-Mansfield Agitation Inventory Alzheimer Disease & Associated Disorders ·Elisabeth Koss, Myron Weiner, Christopher Ernesto, Jiska Cohen‐Mansfield, Steven H. Ferris, Michael Grundman, Kimberly Schafer, Mary Sano, Leon J. Thal, Ronald G. Thomas, Peter J. Whitehouse	1997	117
12	The Spanish Instrument Protocol Alzheimer Disease & Associated Disorders ·Mary Sano, Joan Mackell, Marcel O. Pontón, Paula Ferreira, J.L. Wilson, Sonia Pawluczyk, E. Pfeiffer, Ronald G. Thomas, Shelia Jin, Kimberly Schafer, Mario Schittini, Michael Grundman, Steven H. Ferris, L. J. Thal	1997	19
13	A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease New England Journal of Medicine ·Mary Sano, Christopher Ernesto, Ronald G. Thomas, Melville R. Klauber, Kimberly Schafer, Michael Grundman, Peter Woodbury, John H. Growdon, Carl W. Cotman, Eric Pfeiffer, Lon S. Schneider, Leon J. Thal Hit paper breakdown →	1997	1789
14	Clinical Dementia Rating training and reliability in multicenter studies Neurology ·John C. Morris, Christopher Ernesto, Kimberly Schafer, M. Coats, Susan A. Leon, Mary Sano, L. J. Thal, Peter Woodbury	1997	295
15	Rationale and Design of a Multicenter Study of Selegiline and α-Tocopherol in the Treatment of Alzheimer Disease Using Novel Clinical Outcomes Alzheimer Disease & Associated Disorders ·Mary Sano, Christopher Ernesto, Melville R. Klauber, Kimberly Schafer, Peter Woodbury, Ronald G. Thomas, Michael Grundman, John H. Growdon, Leon J. Thal	1996	46
16	Diagnostic specificity of focal white matter abnormalities in bipolar and unipolar mood disorder Biological Psychiatry ·Renee M. Dupont, Nelson Butters, Kimberly Schafer, Thomine Wilson, John R. Hesselink, J. Christian Gillin	1995	65
17	Cognitive Performance of Alcoholics: A Longitudinal Evaluation of the Role of Drinking History, Depression, Liver Function, Nutrition, and Family History Alcoholism Clinical and Experimental Research ·Kimberly Schafer, Nelson Butters, Tom L. Smith, Michael R. Irwin, Sandra A. Brown, Philip Hanger, Igor Grant, Marc A. Schuckit	1991	53
18	Reduced Cerebral Grey Matter Observed in Alcoholics Using Magnetic Resonance Imaging Alcoholism Clinical and Experimental Research ·Terry L. Jernigan, Nelson Butters, Gina M. Ditraglia, Kimberly Schafer, Thomas J. Smith, Michael R. Irwin, Igor Grant, Marc Schuckit, Laird S. Cermak	1991	282
19	Magnetic resonance imaging of alcoholic Korsakoff patients. PubMed ·Jernigan Tl, Kimberly Schafer, Nelson Butters, Cermak Ls	1991	97
20	Avoiding mental changes and falls in older Parkinson's patients. PubMed ·George W. Paulson, Kimberly Schafer, B Hallum	1986	23

About Kimberly Schafer

Kimberly Schafer is a scholar working on Psychiatry and Mental health, Biological Psychiatry, Geriatrics and Gerontology, Pharmacology and Statistics and Probability, having authored 38 papers that have together received 4.7k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (13 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers), Alzheimer's disease research and treatments (4 papers), Schizophrenia research and treatment (3 papers), Statistical Methods in Clinical Trials (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Tryptophan and brain disorders (2 papers) and Alcoholism and Thiamine Deficiency (2 papers). The work is most often cited by research in Biological Psychiatry (300 citations), Psychiatry and Mental health (1.5k citations), Neurology (753 citations), Physiology (1.9k citations) and Geriatrics and Gerontology (239 citations). Kimberly Schafer has collaborated with scholars based in United States, Germany and Estonia. Frequent co-authors include Mary Sano, Ronald G. Thomas, Michael Grundman, Leon J. Thal, Christopher Ernesto, Eric Pfeiffer, Lon S. Schneider, John H. Growdon, Melville R. Klauber and Carl W. Cotman. Their work appears in journals such as Alzheimer Disease & Associated Disorders, Neurology, Alzheimer s & Dementia, Alcoholism Clinical and Experimental Research and Controlled Clinical Trials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact